CN104287050A - 甜橙多种维生素泡腾片 - Google Patents
甜橙多种维生素泡腾片 Download PDFInfo
- Publication number
- CN104287050A CN104287050A CN201410559935.3A CN201410559935A CN104287050A CN 104287050 A CN104287050 A CN 104287050A CN 201410559935 A CN201410559935 A CN 201410559935A CN 104287050 A CN104287050 A CN 104287050A
- Authority
- CN
- China
- Prior art keywords
- acid
- effervescent tablet
- multivitamin
- calcium
- sweet orange
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007938 effervescent tablet Substances 0.000 title claims abstract description 28
- 235000005976 Citrus sinensis Nutrition 0.000 title claims abstract description 19
- 240000002319 Citrus sinensis Species 0.000 title claims abstract description 19
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 44
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract description 32
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 28
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 27
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 108010011485 Aspartame Proteins 0.000 claims abstract description 17
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000000605 aspartame Substances 0.000 claims abstract description 17
- 235000010357 aspartame Nutrition 0.000 claims abstract description 17
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims abstract description 17
- 229960003438 aspartame Drugs 0.000 claims abstract description 17
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 16
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 16
- 239000011575 calcium Substances 0.000 claims abstract description 16
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 16
- 239000008101 lactose Substances 0.000 claims abstract description 16
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract description 16
- 239000011713 pantothenic acid Substances 0.000 claims abstract description 16
- 229940055726 pantothenic acid Drugs 0.000 claims abstract description 16
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 14
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims abstract description 14
- 229960000304 folic acid Drugs 0.000 claims abstract description 14
- 235000019152 folic acid Nutrition 0.000 claims abstract description 14
- 239000011724 folic acid Substances 0.000 claims abstract description 14
- 229910052742 iron Inorganic materials 0.000 claims abstract description 14
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000011701 zinc Substances 0.000 claims abstract description 13
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 13
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 12
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 11
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 11
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims abstract description 9
- 235000013734 beta-carotene Nutrition 0.000 claims abstract description 9
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims abstract description 9
- 239000011648 beta-carotene Substances 0.000 claims abstract description 9
- 229960002747 betacarotene Drugs 0.000 claims abstract description 9
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims abstract description 9
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 10
- 229960004998 acesulfame potassium Drugs 0.000 claims description 10
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 10
- 239000000619 acesulfame-K Substances 0.000 claims description 10
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 9
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 239000011782 vitamin Substances 0.000 abstract description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 6
- 229940088594 vitamin Drugs 0.000 abstract description 6
- 229930003231 vitamin Natural products 0.000 abstract description 6
- 235000013343 vitamin Nutrition 0.000 abstract description 6
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 4
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 3
- 210000000988 bone and bone Anatomy 0.000 abstract description 3
- 235000012000 cholesterol Nutrition 0.000 abstract description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 abstract 1
- 229960005164 acesulfame Drugs 0.000 abstract 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
- 235000013305 food Nutrition 0.000 description 12
- 229960004106 citric acid Drugs 0.000 description 10
- 229930006000 Sucrose Natural products 0.000 description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000005720 sucrose Substances 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 235000003599 food sweetener Nutrition 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 235000019605 sweet taste sensations Nutrition 0.000 description 7
- 239000003765 sweetening agent Substances 0.000 description 7
- 239000003826 tablet Substances 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229910001868 water Inorganic materials 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- JYMOQWNEIZBVFC-UHFFFAOYSA-N [Fe].[Zn].[Ca] Chemical compound [Fe].[Zn].[Ca] JYMOQWNEIZBVFC-UHFFFAOYSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 102100026189 Beta-galactosidase Human genes 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010018276 Gingival bleeding Diseases 0.000 description 2
- 108010059881 Lactase Proteins 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 235000014171 carbonated beverage Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000020186 condensed milk Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000002079 cooperative effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- -1 iron ion Chemical class 0.000 description 2
- 229940116108 lactase Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 208000037816 tissue injury Diseases 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000189799 Asimina triloba Species 0.000 description 1
- 235000006264 Asimina triloba Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000276331 Citrus maxima Species 0.000 description 1
- 235000001759 Citrus maxima Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010009269 Cleft palate Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 235000004237 Crocus Nutrition 0.000 description 1
- 241000596148 Crocus Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 208000027530 Meniere disease Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 208000006981 Skin Abnormalities Diseases 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 208000025371 Taste disease Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 235000020167 acidified milk Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002460 anti-migrenic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000013574 canned fruits Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 206010009259 cleft lip Diseases 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000006025 fining agent Substances 0.000 description 1
- 235000010855 food raising agent Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000019656 metallic taste Nutrition 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000019533 nutritive sweetener Nutrition 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000001835 salubrious effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种甜橙多种维生素泡腾片,组成及重量比为:柠檬酸10-30%,碳酸氢钠8-25%,乳糖3-8%,山梨糖醇10-30%,阿斯巴甜1-3%,安赛蜜0.5-2%,β-胡萝卜素0.1-0.5%,香精1-2%,硬脂酸镁1-3%,VA1.5%,VB12.2%,VD0.002%,VE0.018%,VB22.2%,VB62.2%,VB82.2%,VB120.007%,烟酸0.033%,叶酸0.6%,泛酸8%,铁0.022%,钙1%,锌0.018%。本发明的甜橙多种维生素泡腾片,添加多种维生素,并增加钙铁锌的含量,能促进骨胶原的生物合成,利于组织创伤口的更快愈合,并改善铁、钙、锌和叶酸的利用,改善脂肪和类脂特别是胆固醇的代谢,预防心血管病,还能促进牙齿和骨骼的生长,防止牙床出血,提高机体抵抗力。
Description
技术领域
本发明涉及保健品技术领域,特别涉及一种甜橙多种维生素泡腾片。
背景技术
泡腾片是近年来广泛应用的一种片剂,它与普通片剂的不同之处,就在于它还含有泡腾崩解剂,当泡腾片放入饮水中之后,在泡腾崩解剂的作用下,即刻产生大量气泡,使片剂迅速崩解和融化,有时崩解产生的气泡还会使药片在水中上下翻滚,加速其崩解和融化。片剂崩解时产生的气体部分溶解于饮水中,使饮水喝入口中时有汽水般的美感。泡腾片有如下的优点 :便于保存和携带 ;崩解快速、服用方便、起效迅速 ;生物利用度高,能提高临床疗效 ;特别适用于儿童、老年人以及吞服药丸困难的患者 ;经过调味后的泡腾片,口味更佳,良药不再苦口,使病人更乐于接受。
现有的维生素泡腾片一般都是以葡萄糖为原料加工而成,葡萄糖属于单糖,而且食用后容易上火,所以一般不建议多食。而且泡腾片中的维生素种类比较单一,不够多元,相互之间也不能有效地促进吸收。
发明内容
本发明需要解决的技术问题是现有的维生素泡腾片维生素种类比较单一,不够多元,相互之间也不能有效地促进吸收。
为解决上述技术问题,本发明提供了一种甜橙多种维生素泡腾片,组成及重量比为:柠檬酸10-30%,碳酸氢钠8-25%,乳糖3-8%,山梨糖醇10-30%,阿斯巴甜1-3%,安赛蜜0.5-2%,β-胡萝卜素0.1-0.5%,香精1-2%,硬脂酸镁1-3%,VA1.5%,VB12.2%,VD0.002%,VE0.018%,VB22.2%,VB62.2%,VB82.2%,VB120.007%,烟酸0.033%,叶酸0.6%,泛酸8%,铁0.022%,钙1%,锌0.018%。
作为本发明的优选技术方案,所述的甜橙多种维生素泡腾片,其组成及重量比为:柠檬酸20-25%,碳酸氢钠15-22%,乳糖4-6%,山梨糖醇20-25%,阿斯巴甜1-3%,安赛蜜0.5-2%,β-胡萝卜素0.1-0.5%,香精1-2%,硬脂酸镁1-3%,VA1.5%,VB12.2%,VD0.002%,VE0.018%,VB22.2%,VB62.2%,VB82.2%,VB120.007%,烟酸0.033%,叶酸0.6%,泛酸8%,铁0.022%,钙1%,锌0.018%。
本发明的甜橙多种维生素泡腾片,添加多种维生素,并增加钙铁锌的含量,能促进骨胶原的生物合成,利于组织创伤口的更快愈合,并改善铁、钙、锌和叶酸的利用,改善脂肪和类脂特别是胆固醇的代谢,预防心血管病,还能促进牙齿和骨骼的生长,防止牙床出血,提高机体抵抗力。
具体实施方式
下面详细说明本发明的优选技术方案。
实施例一
本发明的甜橙多种维生素泡腾片,其组成及重量比为:柠檬酸22%,碳酸氢钠22%,乳糖5.5%,山梨糖醇22%,阿斯巴甜2.5%,安赛蜜1.5%,β-胡萝卜素0.5%,香精1.5%,硬脂酸镁2.5%,VA1.5%,VB12.2%,VD0.002%,VE0.018%,VB22.2%,VB62.2%,VB82.2%,VB120.007%,烟酸0.033%,叶酸0.6%,泛酸8%,铁0.022%,钙1%,锌0.018%。
实施例二
本发明的甜橙多种维生素泡腾片,其组成及重量比为:柠檬酸21%,碳酸氢钠21%,乳糖6%,山梨糖醇23%,阿斯巴甜3%,安赛蜜1.7%,β-胡萝卜素0.3%,香精1.7%,硬脂酸镁2.3%,VA1.5%,VB12.2%,VD0.002%,VE0.018%,VB22.2%,VB62.2%,VB82.2%,VB120.007%,烟酸0.033%,叶酸0.6%,泛酸8%,铁0.022%,钙1%,锌0.018%。
实施例三
本发明的甜橙多种维生素泡腾片,其组成及重量比为:柠檬酸23%,碳酸氢钠22%,乳糖5%,山梨糖醇21%,阿斯巴甜2%,安赛蜜2%,β-胡萝卜素0.4%,香精1.8%,硬脂酸镁2.8%,VA1.5%,VB12.2%,VD0.002%,VE0.018%,VB22.2%,VB62.2%,VB82.2%,VB120.007%,烟酸0.033%,叶酸0.6%,泛酸8%,铁0.022%,钙1%,锌0.018%。
本发明的甜橙多种维生素泡腾片,一般为4g/片,
本发明的甜橙多种维生素泡腾片,添加多种维生素,并增加钙铁锌的含量,能促进骨胶原的生物合成,利于组织创伤口的更快愈合,并改善铁、钙、锌和叶酸的利用,改善脂肪和类脂特别是胆固醇的代谢,预防心血管病,还能促进牙齿和骨骼的生长,防止牙床出血,提高机体抵抗力。
柠檬酸因为柠檬酸有温和爽快的酸味,普遍用于各种饮料、汽水、葡萄酒、糖果、点心、饼干、罐头果汁、乳制品等食品的制造。在所有有机酸的市场中,柠檬酸市场占有率 70%以上,调味剂,也可用作食用油的抗氧化剂。同时改善食品的感官性状,增强食欲和促进体内钙、磷物质的消化吸收。无水柠檬酸大量用于固体饮料。柠檬酸的盐类如柠檬酸钙和柠檬酸铁是某些食品中需要添加钙离子和铁离子的强化剂。柠檬酸的酯类如柠檬酸三乙酯可作无毒增塑剂,制造食品包装用塑料薄膜,是饮料和食品行业的酸味剂,防腐剂。
碳酸氢钠(NaHCO?)(Sodium Bicarbonate),白色细小晶体,在水中的溶解度小于碳酸钠。固体50℃以上开始逐渐分解生成碳酸钠、二氧化碳和水,270℃时完全分解。碳酸氢钠是强碱与弱酸中和后生成的酸式盐,溶于水时呈现弱碱性。此特性可使其作为食品制作过程中的膨松剂。
乳糖甜度是蔗糖的约六分之一,乳中2-8%的固体成分为乳糖。软糖发酵乳必不可少,提供碳源。乳糖在乳酸菌的作用下,分解成半乳糖和葡萄糖。为人类提供营养、提供能源。半乳糖对哺乳动物神经发育有重要影响。乳糖有利于钙的吸收。乳糖酶缺少会引起乳糖不耐症。对乳制品组织状态有重要影响。炼乳生产,乳糖结晶对炼乳口感的影响。奶粉的溶解性。对乳制品的颜色、风味有重要影响。褐变反应。发酵后风味形成。乳糖在肠道内不易被分解,可在肠道内长时间滞留。乳糖经乳糖酶作用后形成有机酸,会使肠道PH值下降,在酸的作用下可促进钙离子的吸收。另外,乳糖分解后形成的葡萄糖也有促进钙质吸收的作用。
山梨糖醇可由葡萄糖还原而制取,在梨、桃、苹果中广泛分布,含量约为1%~2%。其甜度与葡萄糖相当,但能给人以浓厚感。在体内被缓慢地吸收利用,且血糖值不增加。其还是比较好的保湿剂和界面活性剂。它是在日本最早允许作为食品添加剂使用的糖醇之一,用于提高食品保湿性,或作为稠化剂之用。可作甜味剂,是一种营养性甜味剂、湿润剂、螯合剂和稳定剂。是一种具有保湿功能的特殊甜味剂。
阿斯巴甜是一种天然功能性低聚糖,不致龋齿、甜味纯正、吸湿性低,没有发黏现象。不会引起血糖的明显升高,适合糖尿病患者食用。 它比一般的糖甜约200倍,又比一般蔗糖含更少的热量;一克的阿斯巴甜约有4千卡的热量。但使人感到到甜味所需的阿斯巴甜量非常少,以致于可忽略其所含的热量,因此也被广泛地作为蔗糖的代替品。阿斯巴甜的味道和一般蔗糖的味道有所不同。阿斯巴甜的甜味与糖相比较,可延缓及持续较长的时间。阿斯巴甜安全性明确,被所谓的联合国食品添加剂委员会列为GRAS级(一般公认为安全的),为所有代糖中对人体安全研究最为彻底的产品,至今已有世界各地100多个国家的6000多种产品中19年的成功使用经验。甜味纯正,具有和蔗糖极其近似的清爽甜味,无苦涩后味和金属味,是迄今开发成功的甜味最接近蔗糖的甜味剂。阿斯巴甜的甜度是蔗糖的180倍,在应用中仅需少量就可达到希望的甜度,所以在食品和饮料中使用阿斯巴甜替代糖,可显著降低热量并不会造成龋齿。与蔗糖或其他甜味剂混合使用有协同效应,如加2%~3%于糖精中,可明显掩盖糖精的不良口感。与香精混合,具有极佳的增效性,尤其是对酸性的柑桔、柠檬、柚子等,能使香味持久、减少芳香剂用量。蛋白质成分,可被人体自然吸收分解。
安赛蜜是一种食品添加剂,是化学品,类似于糖精,易溶于水,增加食品甜味的,没有营养,口感好,无热量,具有在人体内不代谢、不吸收(是中老年人、肥胖病人、糖尿病患者理想的甜味剂),对热和酸稳定性好等特点,是当前世界上第四代合成甜味剂。它和其它甜味剂混合使用能产生很强的协同效应,一般浓度下可增加甜度30%~50%。安赛蜜具有强烈甜味,甜度约为蔗糖的130倍,呈味性质与糖精相似。高浓度时有苦味。
β—胡萝卜素(C40H56)是类胡萝卜素之一,也是橘黄色脂溶性化合物,它是自然界中最普遍存在也是最稳定的天然色素。许多天然食物中例如:绿色蔬菜、甘薯、胡萝卜、菠菜、木瓜、芒果等,皆存有丰富的β—胡萝卜素。β—胡萝卜素是一种抗氧化剂,具有解毒作用,是维护人体健康不可缺少的营养素,在抗癌、预防心血管疾病、白内障及抗氧化上有显著的功能,并进而防止老化和衰老引起的多种退化性疾病。
硬脂酸镁为白色轻松无砂性的细粉;微有特臭;与皮肤接触有滑腻感。本品在水、乙醇或乙醚中不溶,主要用作润滑剂、抗粘剂、助流剂。特别适宜油类、浸膏类药物的制粒,制成的颗粒具有很好的流动性和可压性。在直接压片中用作助流剂。还可作为助滤剂、澄清剂和滴泡剂,以及液体制剂的助悬剂、增稠剂。
多种维生素包括VA,VB1,VD,VE,VB2,VB6,VB8和VB12。
烟酸也称作维生素B3, 有较强的扩张周围血管作用临床用于治 疗头痛、偏头痛、耳鸣、内耳眩晕症等。
叶酸又称维生素M,可以用来治疗女性贫血,可防止新生儿体重过轻、早产以及婴儿腭裂(兔唇)等先天性畸形。
泛酸也称作维生素B5、遍多酸,无臭,味微苦,因其性质偏酸性并广泛存于多种食物中,故而得名。一般公认泛酸与头发、皮肤的营养状态密切相关,当头发缺乏光泽或变得较稀疏时,多补充泛酸可见其效;制造抗体也是泛酸的作用之一,能帮助人体抵抗传染病,缓和多种抗生素副作用及毒性,减轻过敏症状。泛酸缺乏易引起血液及皮肤异常,产生低血糖等症。
本发明的甜橙多种维生素泡腾片,通过多种维生素以及烟酸、叶酸和泛酸等的添加,使得泡腾片营养丰富,其中钙铁锌的增加,使得泡腾片中富含微量元素,而且维生素和微量元素能相互促进吸收,本发明的甜橙多种维生素泡腾片,既具有保健作用又具有预防作用,老人小孩以及孕妇均可饮用。
Claims (3)
1.一种甜橙多种维生素泡腾片,其特征在于组成及重量比为:柠檬酸10-30%,碳酸氢钠8-25%,乳糖3-8%,山梨糖醇10-30%,阿斯巴甜1-3%,安赛蜜0.5-2%,β-胡萝卜素0.1-0.5%,香精1-2%,硬脂酸镁1-3%,VA1.5%,VB12.2%,VD0.002%,VE0.018%,VB22.2%,VB62.2%,VB82.2%,VB120.007%,烟酸0.033%,叶酸0.6%,泛酸8%,铁0.022%,钙1%,锌0.018%。
2.如权利要求1所述的甜橙多种维生素泡腾片,其特征在于组成及重量比为:柠檬酸20-25%,碳酸氢钠15-22%,乳糖4-6%,山梨糖醇20-25%,阿斯巴甜1-3%,安赛蜜0.5-2%,β-胡萝卜素0.1-0.5%,香精1-2%,硬脂酸镁1-3%,VA1.5%,VB12.2%,VD0.002%,VE0.018%,VB22.2%,VB62.2%,VB82.2%,VB120.007%,烟酸0.033%,叶酸0.6%,泛酸8%,铁0.022%,钙1%,锌0.018%。
3.如权利要求2所述的甜橙多种维生素泡腾片,其特征在于组成及重量比为:柠檬酸22%,碳酸氢钠22%,乳糖5.5%,山梨糖醇22%,阿斯巴甜2.5%,安赛蜜1.5%,β-胡萝卜素0.5%,香精1.5%,硬脂酸镁2.5%,VA1.5%,VB12.2%,VD0.002%,VE0.018%,VB22.2%,VB62.2%,VB82.2%,VB120.007%,烟酸0.033%,叶酸0.6%,泛酸8%,铁0.022%,钙1%,锌0.018%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410559935.3A CN104287050A (zh) | 2014-10-21 | 2014-10-21 | 甜橙多种维生素泡腾片 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410559935.3A CN104287050A (zh) | 2014-10-21 | 2014-10-21 | 甜橙多种维生素泡腾片 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104287050A true CN104287050A (zh) | 2015-01-21 |
Family
ID=52307218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410559935.3A Pending CN104287050A (zh) | 2014-10-21 | 2014-10-21 | 甜橙多种维生素泡腾片 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104287050A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108969503A (zh) * | 2017-05-31 | 2018-12-11 | 江苏汉典生物科技股份有限公司 | 多种维生素泡腾片及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1593241A (zh) * | 2003-09-12 | 2005-03-16 | 深圳市海川实业股份有限公司 | 天然营养素泡腾片 |
CN1759825A (zh) * | 2004-10-11 | 2006-04-19 | 江西本草天工科技有限责任公司 | 含铁锌钙多种维生素的泡腾片及其环形制剂与制备方法 |
CN102114112A (zh) * | 2011-02-28 | 2011-07-06 | 辽宁盛生医药集团有限公司 | 一种提高免疫力的泡腾片及其制备方法 |
-
2014
- 2014-10-21 CN CN201410559935.3A patent/CN104287050A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1593241A (zh) * | 2003-09-12 | 2005-03-16 | 深圳市海川实业股份有限公司 | 天然营养素泡腾片 |
CN1759825A (zh) * | 2004-10-11 | 2006-04-19 | 江西本草天工科技有限责任公司 | 含铁锌钙多种维生素的泡腾片及其环形制剂与制备方法 |
CN102114112A (zh) * | 2011-02-28 | 2011-07-06 | 辽宁盛生医药集团有限公司 | 一种提高免疫力的泡腾片及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108969503A (zh) * | 2017-05-31 | 2018-12-11 | 江苏汉典生物科技股份有限公司 | 多种维生素泡腾片及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6014197B2 (ja) | スクラロースを含有する組成物及びその応用 | |
CN103202417B (zh) | 一种可吸式琼脂果冻 | |
CN104382004A (zh) | 一种针叶樱桃vc泡腾片 | |
CN105248646A (zh) | 一种含乳饮料及其制备方法 | |
CN104366648A (zh) | 甜橙vc泡腾片 | |
CN104305464A (zh) | 蓝莓c+e泡腾片 | |
CN104287050A (zh) | 甜橙多种维生素泡腾片 | |
CN104544374A (zh) | 一种蜂蜜花香果汁及其制作方法 | |
CN102960507A (zh) | 一种菊花柚子茶及其制作方法 | |
CN107951034B (zh) | 维生素泡腾制剂及其制备方法 | |
CN106689370A (zh) | 一种果味酸奶的制备方法 | |
CN107712185A (zh) | 一种柠檬柚子蜂蜜茶及其制备方法 | |
JP7336970B2 (ja) | パフィア含有酸性飲食物 | |
KR100283417B1 (ko) | 무인산 및 무카페인 탄산음료 | |
JP6849281B2 (ja) | 肝臓加水分解物とドクダミエキスを含む組成物 | |
CN104605437A (zh) | 一种适合孕妇食用的保健饮料及其制备方法 | |
CN104382056A (zh) | 一种胶原蛋白泡腾片 | |
KR20010000741A (ko) | 유소아용 건강보조음료 조성물 및 그의 제조방법 | |
CN103349239B (zh) | 一种甜橙罐头及其制备方法 | |
CN115736193A (zh) | 一种卡曼橘柠檬红茶无骨鸡爪的加工方法 | |
CN107410497A (zh) | 一种甜牛奶及其制备方法 | |
KR20010000742A (ko) | 미혼여성용 건강보조음료 조성물 및 그의 제조방법 | |
CN104381876A (zh) | 一种黑加仑多种维生素泡腾片 | |
CN106889232A (zh) | 一种具有美容功效的奶茶及其制备方法 | |
KR20130110264A (ko) | 오미자 비타민 영양제의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150121 |